{
    "clinical_study": {
        "@rank": "50503", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells.\n\n      PURPOSE: Randomized clinical trial to study the effectiveness of vinorelbine plus\n      fluorouracil in treating women who have metastatic breast cancer that has been previously\n      treated with at least one regimen of chemotherapy."
        }, 
        "brief_title": "Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the least toxic time of vinorelbine administration when combined with\n           chronomodulated fluorouracil in women with previously treated metastatic breast cancer.\n\n        -  Determine the toxic effects and dose intensities of each drug in these women.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to prior\n      chemotherapy (second line vs third line) and participating center. Patients are randomized\n      to 1 of 8 vinorelbine dosing times (0000, 0300, 0600, 0900, 1200, 1500, 1800, or 2100).\n\n      Patients receive vinorelbine IV over 20 minutes on days 1 and 6 and fluorouracil IV over 12\n      hours according to a chronomodulated delivery rate (2200 to 1000 with a maximum dose at\n      0400) on days 1-4. Treatment repeats every 3 weeks for at least 3 courses in the absence of\n      unacceptable toxicity.\n\n      Patients are followed for 30 days.\n\n      PROJECTED ACCRUAL: A minimum of 80 patients (10 per dosing time) will be accrued for this\n      study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed metastatic breast cancer\n\n          -  At least 1 line of prior chemotherapy for metastatic disease (adjuvant or neoadjuvant\n             chemotherapy is considered first line if completed less than one year prior to\n             palliative chemotherapy)\n\n          -  No cerebral metastases\n\n          -  Hormonal receptor status:\n\n               -  Not specified\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Not specified\n\n        Sex:\n\n          -  Female\n\n        Menopausal status:\n\n          -  Not specified\n\n        Performance status:\n\n          -  WHO 0-2\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Absolute neutrophil count at least 1,500/mm^3\n\n          -  Platelet count at least 100,000/mm ^3\n\n        Hepatic:\n\n          -  Bilirubin no greater than 2.5 times upper limit of normal (ULN)\n\n          -  AST/ALT no greater than 2.5 times ULN\n\n        Renal:\n\n          -  Creatinine no greater than 1.58 mg/dL\n\n        Cardiovascular:\n\n          -  No clinically significant cardiac insufficiency or ischemic disease\n\n        Pulmonary:\n\n          -  No bronchoconstriction other than pulmonary lymphangitis\n\n        Other:\n\n          -  No serious chronic disease\n\n          -  No bowel obstruction\n\n          -  Not pregnant or nursing\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No concurrent immunotherapy\n\n          -  No concurrent prophylactic growth factor\n\n        Chemotherapy:\n\n          -  See Disease Characteristics\n\n          -  At least 4 weeks since prior chemotherapy\n\n          -  No prior high-dose chemotherapy\n\n          -  No other concurrent chemotherapy\n\n        Endocrine therapy:\n\n          -  No concurrent hormonal therapy\n\n          -  No concurrent steroid therapy except in an emergency\n\n        Radiotherapy:\n\n          -  At least 4 weeks since prior radiotherapy (for primary tumor or axillary or mammary\n             chain treatment only)\n\n          -  No concurrent radiotherapy\n\n        Surgery:\n\n          -  Not specified\n\n        Other:\n\n          -  No other concurrent antitumor therapy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003730", 
            "org_study_id": "EORTC-05971", 
            "secondary_id": "EORTC-05971"
        }, 
        "intervention": [
            {
                "intervention_name": "fluorouracil", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "vinorelbine tartrate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluorouracil", 
                "Vinorelbine", 
                "Vinblastine"
            ]
        }, 
        "keyword": [
            "stage IV breast cancer", 
            "recurrent breast cancer"
        ], 
        "lastchanged_date": "June 29, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-05971"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Antwerpen", 
                        "country": "Belgium", 
                        "zip": "2010"
                    }, 
                    "name": "VZW Monica Campus Eeuwfeestkliniek"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liege", 
                        "country": "Belgium", 
                        "zip": "B 4000"
                    }, 
                    "name": "C.H.C - Asbl"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liege", 
                        "country": "Belgium", 
                        "zip": "B-4000"
                    }, 
                    "name": "CHU Liege - Domaine Universitaire du Sart Tilman"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63011"
                    }, 
                    "name": "Centre Jean Perrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21079"
                    }, 
                    "name": "Centre de Lutte Contre le Cancer Georges-Francois Leclerc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Levallois-Perret", 
                        "country": "France", 
                        "zip": "92300"
                    }, 
                    "name": "Hopital Perpetuel Secours"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87042"
                    }, 
                    "name": "Centre Hospital Regional Universitaire de Limoges"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75475"
                    }, 
                    "name": "Hopital Saint-Louis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Cloud", 
                        "country": "France", 
                        "zip": "92211"
                    }, 
                    "name": "Centre Rene Huguenin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Etienne", 
                        "country": "France", 
                        "zip": "42055"
                    }, 
                    "name": "Hopital Bellevue"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "94804"
                    }, 
                    "name": "Hopital Paul Brousse"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iraklion (Heraklion)", 
                        "country": "Greece", 
                        "state": "Crete", 
                        "zip": "71110"
                    }, 
                    "name": "University Hospital of Heraklion"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Candiolo (Turin)", 
                        "country": "Italy", 
                        "zip": "10180"
                    }, 
                    "name": "Istituto per la Ricerca e Cura del Cancro"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano (Milan)", 
                        "country": "Italy", 
                        "zip": "20153"
                    }, 
                    "name": "Ospedale San Carlo Borromeo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orbassano, (Torino)", 
                        "country": "Italy", 
                        "zip": "10043"
                    }, 
                    "name": "Azienda Ospedale S. Luigi - Universita Di Turin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "zip": "I-27100"
                    }, 
                    "name": "Fondazione Salvatore Maugeri"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy", 
                        "zip": "00161"
                    }, 
                    "name": "Istituti Fisioterapici Ospitalieri - Roma"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France", 
                "Greece", 
                "Italy"
            ]
        }, 
        "official_title": "A Multicenter Randomized Trial, With Direct Individual Benefit, to Determine the Optimal Circadian Time of Vinorelbine Administration Combined With Chronomodulated Infusion of 5-Fluorouracil in Previously Treated Patients With Metastatic Breast Cancer", 
        "overall_official": {
            "affiliation": "Centre de Lutte Contre le Cancer Georges-Francois Leclerc", 
            "last_name": "Bruno Coudert, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2004", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003730"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "18780198", 
                "citation": "Coudert B, Focan C, Genet D, Giacchetti S, Cvickovic F, Zambelli A, Fillet G, Chollet P, Amoroso D, Van Der Auwera J, Lentz MA, Marreaud S, Baron B, Gorlia T, Biville F, L\u00e9vi F. A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971. Chronobiol Int. 2008 Sep;25(5):680-96."
            }, 
            {
                "citation": "Coudert B, Focan C, Genet D, et al.: Optimal circadian time of vinorelbine (V) combined with chronomodulated 5-FU in pretreated metastatic breast cancer patients. EORTC 05971 randomized multicenter study. [Abstract] J Clin Oncol 24 (Suppl 18): A-2066, 2006."
            }
        ], 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 1998", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2012"
    }, 
    "geocoordinates": {
        "Azienda Ospedale S. Luigi - Universita Di Turin": "45.007 7.537", 
        "C.H.C - Asbl": "50.633 5.58", 
        "CHU Liege - Domaine Universitaire du Sart Tilman": "50.633 5.58", 
        "Centre Hospital Regional Universitaire de Limoges": "45.834 1.261", 
        "Centre Jean Perrin": "45.777 3.087", 
        "Centre Rene Huguenin": "48.848 2.208", 
        "Centre de Lutte Contre le Cancer Georges-Francois Leclerc": "47.322 5.041", 
        "Fondazione Salvatore Maugeri": "45.186 9.157", 
        "Hopital Bellevue": "45.44 4.387", 
        "Hopital Paul Brousse": "48.793 2.359", 
        "Hopital Perpetuel Secours": "48.893 2.288", 
        "Hopital Saint-Louis": "48.857 2.352", 
        "Istituti Fisioterapici Ospitalieri - Roma": "41.891 12.494", 
        "Istituto per la Ricerca e Cura del Cancro": "44.96 7.603", 
        "Ospedale San Carlo Borromeo": "45.464 9.188", 
        "University Hospital of Heraklion": "35.329 25.139", 
        "VZW Monica Campus Eeuwfeestkliniek": "51.219 4.403"
    }
}